Biomaterials and polymers are increasingly combined with drugs and biologics. Regenerative products may have medical device–based scaffolding and may be treated as biologics, reflecting the cell and tissue components. Therefore, biomaterials, medical device components, and 3-D printed materials need...

Hundreds of millions of dollars are available to small biotechnology and medical device businesses to fight COVID-19. The money is in the form of non-dilutive grants, contracts,  and also in exchange for equity positions in your company. For example start-up incubators may offer small seed fund...